Novavax
NVAX
#5434
Rank
NZ$2.50 B
Marketcap
NZ$15.22
Share price
-1.66%
Change (1 day)
28.53%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): NZ$0.81 Billion

According to Novavax's latest financial reports the company's current earnings are NZ$1.08 Billion. , an increase over its 2024 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.79 B-396.87%
2024 -NZ$0.27 Billion-70.39%
2023 -NZ$0.91 Billion-16.59%
2022 -NZ$1.09 Billion-62.58%
2021 -NZ$2.91 Billion320.54%
2020 -NZ$0.7 Billion234.22%
2019 -NZ$0.21 Billion-30.17%
2018 -NZ$0.3 Billion1.69%
2017 -NZ$0.3 Billion-36.44%
2016 -NZ$0.46 Billion70.4%
2015 -NZ$0.27 Billion89.27%
2014 -NZ$0.15 Billion59.83%
2013 -NZ$88.77 Million81.9%
2012 -NZ$48.8 Million50.33%
2011 -NZ$32.47 Million
2009 -NZ$64.07 Million8.8%
2008 -NZ$58.89 Million18.01%
2007 -NZ$49.9 Million18.33%
2006 -NZ$42.17 Million168.31%
2005 -NZ$15.72 Million-62.51%
2004 -NZ$41.93 Million52.4%
2003 -NZ$27.52 Million-28.21%
2002 -NZ$38.32 Million
2000 -NZ$21.84 Million177%
1999 -NZ$7.89 Million-11.54%
1998 -NZ$8.92 Million10.64%
1997 -NZ$8.06 Million-9.62%
1996 -NZ$8.92 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
NZ$27.04 B 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.14 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.12 B 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$17.15 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-NZ$1.21 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.5 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.41 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$13.93 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$0.45 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$0.28 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA